MEI6570

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameMEI6570
Drug Alias NameMEI6570MEI-6570
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionOxidized low-density lipoprotein receptor 1 inhibitors
TargetsOxidized low-density lipoprotein receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Peripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesNational University Health SystemNational Heart Centre Singapore
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Peripheral Arterial Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A